A group of investors led by the private equity fund ALDIR I slhf. has acquired a 50% stake in Algalíf ehf. from Kenneth G. Bern and Andres K. Flaaten. The company’s management team remains unchanged under the leadership of CEO Orri Björnsson.
Algalíf is an Icelandic biotechnology company that produces sustainable, natural astaxanthin from microalgae, primarily used in dietary supplements. The company is an award-winning global leader in sustainability, production technology, science, and product quality. All energy used in its production comes from local, renewable geothermal power.
Founded in 2012, Algalíf Iceland currently employs around 80 people. The company is completing a major expansion project that triples its production capacity compared to previous years.
The new owners have expressed their commitment to continuing the company’s growth, with plans to expand production capacity, advance product development, and strengthen global market presence.
“This is a milestone for Algalíf. With strong new partners on board, we are well positioned for continued growth, innovation, and stronger global reach. We are confident that even greater success lies ahead,” says Orri Björnsson, CEO of Algalíf.
